BrainsWay 2021 logo.jpg
Brainsway's Deep TMS System to be Marketed and Distributed in Japan
23 sept. 2013 12h16 HE | BrainsWay Ltd.
JERUSALEM, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") is pleased to announce the execution of an agreement for the marketing and distribution of its...
BrainsWay 2021 logo.jpg
Brainsway Receives FDA Approval of IDE for Multi-Center Smoking Cessation Study
11 sept. 2013 13h30 HE | BrainsWay Ltd.
JERUSALEM, Sept. 11, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that the U.S. Food and Drug Administration ("FDA") has approved an IDE ("Investigational Device...
BrainsWay 2021 logo.jpg
Brainsway Reports Positive Final Results of Study Using Deep TMS to Treat OCD
04 sept. 2013 07h48 HE | BrainsWay Ltd.
JERUSALEM, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to report the final results of a clinical trial conducted at the Sheba Medical Center at Tel Hashomer to assess the...
BrainsWay 2021 logo.jpg
Brainsway Provides Commercialization Progress Update
22 juil. 2013 16h01 HE | BrainsWay Ltd.
JERUSALEM, July 22, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") announced today that, further to its press release of May 1, 2013, there are now approximately 50...
BrainsWay 2021 logo.jpg
Brainsway Poised for Commercial Launch of Deep TMS in the United States
01 mai 2013 08h30 HE | BrainsWay Ltd.
JERUSALEM, May 1, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") is proud to announce that, after completing production of approximately 100 Deep TMS systems, it...
BrainsWay 2021 logo.jpg
Brainsway Announces Final Results in Clinical Trial for Smoking Cessation in Chronic Obstructive Pulmonary Disease Patients
24 janv. 2013 15h54 HE | BrainsWay Ltd.
JERUSALEM, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company) is pleased to announce that it has received final results with respect to a clinical trial that...
BrainsWay 2021 logo.jpg
Brainsway Receives Health Canada Approval
16 janv. 2013 16h10 HE | BrainsWay Ltd.
JERUSALEM, Jan. 16, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") announced today that it has received a medical device license to market its Deep TMS system in...
BrainsWay 2021 logo.jpg
Brainsway Receives FDA Approval
10 janv. 2013 12h14 HE | BrainsWay Ltd.
JERUSALEM, Jan. 10, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") is proud to announce that the U.S. Food and Drug Administration ("FDA") has approved its...
BrainsWay 2021 logo.jpg
Multiple Sclerosis Clinical Trial - Final Results
13 nov. 2012 16h58 HE | BrainsWay Ltd.
JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2011 regarding the double-blind clinical trial being conducted at the Charité...
BrainsWay 2021 logo.jpg
Brainsway Announces Breakthrough Results in Clinical Trials in Parkinson's, Migraine and More
13 nov. 2012 12h35 HE | BrainsWay Ltd.
JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to Brainsway's (TASE:BRIN) announcement regarding the association between Brainsway and Advanced Technologies Innovation Distribution SRL ("ATID")...